RAYMOND JAMES & ASSOCIATES - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 25 filers reported holding VIRIOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,744
-33.0%
30,0000.0%0.00%
Q2 2023$41,400
+275.5%
30,0000.0%0.00%
Q1 2023$11,025
+55.7%
30,0000.0%0.00%
Q4 2022$7,080
-45.5%
30,000
-14.3%
0.00%
Q3 2022$13,00035,0000.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 80,590$30,664,0000.12%
Warberg Asset Management LLC 200,000$74,0000.01%
Koshinski Asset Management, Inc. 40,924$16,0000.00%
&PARTNERS 11,000$4,0000.00%
Virtu Financial LLC 47,765$18,0000.00%
Walleye Capital LLC 150,000$57,0000.00%
UBS Group AG 41,041$16,0000.00%
OSAIC HOLDINGS, INC. 8,621$3,0000.00%
WELLS FARGO & COMPANY/MN 48$00.00%
NORTHERN TRUST CORP 15,836$6,0000.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders